These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 16644341)
1. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes. Navarro Estrada JL; Rubinstein F; Bahit MC; Rolandi F; Perez de Arenaza D; Gabay JM; Alvarez J; Sarmiento R; Rojas Matas C; Sztejfman C; Tettamanzi A; de Miguel R; Guzman L; Am Heart J; 2006 May; 151(5):1093.e1-7. PubMed ID: 16644341 [TBL] [Abstract][Full Text] [Related]
2. NT-ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non-ST-elevation acute coronary syndrome. Riezebos RK; Ronner E; Tijssen JG; Laarman GJ Acute Card Care; 2006; 8(1):51-7. PubMed ID: 16720429 [TBL] [Abstract][Full Text] [Related]
3. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy. Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700 [TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related]
5. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study. Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244 [TBL] [Abstract][Full Text] [Related]
6. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes. Ndrepepa G; Braun S; Mehilli J; Niemöller K; Schömig A; Kastrati A Clin Res Cardiol; 2007 Jan; 96(1):30-7. PubMed ID: 17066344 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes. Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores. Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547 [TBL] [Abstract][Full Text] [Related]
9. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781 [TBL] [Abstract][Full Text] [Related]
10. Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction. Wu N; Ma F; Guo Y; Li X; Liu J; Qing P; Xu R; Zhu C; Jia Y; Liu G; Dong Q; Jiang L; Li J Chin Med J (Engl); 2014; 127(4):627-32. PubMed ID: 24534213 [TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD; Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869 [TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization. Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525 [TBL] [Abstract][Full Text] [Related]
17. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function. Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773 [TBL] [Abstract][Full Text] [Related]
18. Dynamics in N-terminal pro-brain natriuretic peptide concentration in patients with non-ST-elevation acute coronary syndrome. Riezebos RK; Ronner E; de Boer BA; Slaats EH; Tijssen JG; Laarman GJ Am Heart J; 2005 Dec; 150(6):1255-9. PubMed ID: 16338268 [TBL] [Abstract][Full Text] [Related]
19. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes? Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352 [TBL] [Abstract][Full Text] [Related]
20. N-terminal probrain natriuretic peptide in patients with acute coronary syndrome . Kang Q; Wan Z; Huang Z Int J Clin Pharmacol Ther; 2017 Jan; 55(1):78-84. PubMed ID: 27879192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]